Events
CASSS Cell and Gene Therapy Products 2026 | 09–11 June 2026 | Rockville, MD
May Guo, VP Busines Development, will chair the session on Characterization and Quality Expectations for mRNA in Various Applications and present Biomay’s mRNA manufacturing process.
Bio International Convention | 22–25 June 2026 | San Diego, CA
We are heading to the heart of the Californian biotech cluster! Meet Hans Huber, CEO, Hauke Hüttmann, VP Manufacturing, and May Guo, VP Business Development, at Booth 5454 to discuss global partnerships and scalable manufacturing solutions.
CPhI Worldwide | 06–08 October 2026 | Milan, Italy
Christian Gruber, Manager Client Business, and Konstantin Tomanov, BD Manager.
33rd ESGCT Congress | 27–30 October 2026 | Hamburg, Germany
Biomay is a Silver Sponsor of the 33rd ESGCT Congress in Hamburg. Stop by Booth B-12 and let us talk about your next program.
AMM ASCENT | 29–30 October 2026 | Coronado, CA
BIO-Europe | 09–11 November 2026 | Cologne, Germany
Meet Konstantin Tomanov to discuss how Biomay can best support your manufacturing needs.
International mRNA Health Conference | 16–19 November 2026 | Boston, USA
Recent Events
ASGCT Annual Meeting | 11–15 May 2026 | Boston, MA
Join us at Booth 1077! Our team is bringing fresh insights to Boston:
- Dr. Hans Huber, CEO will present on “Manufacturing of mRNA by fed-batch in vitro transcription.”
- Dr. Linda Gombos, VP MSAT will discuss “Analysis of critical quality attributes of mRNA encapsulated in lipid nanoparticles by mass spectrometry.”
Stop by to chat with Hans, Linda, and May Guo, VP Business Development, about supporting your next gene therapy milestone.
BioProcess International | 27–30 April 2026 | Vienna, Austria
Robin Hoheneder, Team Leader MSAT, and Radwan Abdur, Team Leader DSP will be walking the floor to explore the latest breakthroughs in bioprocessing. We would love to meet you there, so reach out to book an appointment.
RNA Leaders Europe | 17–19 March 2026 | Vienna, Austria
Visit us at Booth 21 to speak with Dr. Linda Gombos, VP MSAT, or Dr. Konstantin Tomanov, BD Manager. Don’t miss the talk on “Intensification of mRNA manufacturing in an end-to-end GMP process platform” presented by Dr. Hans Huber, CEO, to learn about our latest process innovations.
Did you miss us? Click the button and let us arrange a meeting at the next conference.